What Makes Globus Medical (GMED) a New Buy Stock [Yahoo! Finance]
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: Yahoo! Finance
The upgrade reflects a positive comment on the company's earnings outlook, which could have a favorable impact on its stock price. Analysts have been steadily raising their estimates for Globus Medical, with the Zacks Consensus Estimate increasing 4.4% over the past three months. The company is expected to earn $2.97 per share in 2024, a 28% change from the year-ago reported number. The upgrade positions Globus Medical in the top 20% of Zacks-covered stocks in terms of estimate revisions, implying potential for the stock to move higher in the near term. Globus Medical (GMED) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock throu
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- Reasons to Add GMED Stock to Your Portfolio Right Now [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.MarketBeat
- Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.MarketBeat
GMED
Earnings
- 11/5/24 - Beat
GMED
Sec Filings
- 12/4/24 - Form 4
- 12/2/24 - Form 144
- 11/25/24 - Form 4
- GMED's page on the SEC website